top of page

Iter Investments, in Collaboration with MAPS ISRAEL, Hosted an Intimate Shabbat Experience in Support of MAPS ISRAEL's Healing, Oct7 Initiative

MAPS ISRAEL, which stands for the Multidisciplinary Association for Psychedelic Studies – Israel, is an Israeli nonprofit organization at the forefront of Israeli public education and research development on the therapeutic potential of psychedelics. MAPS ISRAEL launched its HealingOct7 Initiative, which is an MDMA group therapeutic study aimed at offering healing and support to survivors traumatized by the Oct. 7 attacks. 

Photo credit: World Red Eye / Isaac Gill

This groundbreaking initiative holds profound implications, tapping into a tradition of utilizing sacred medicines within groups and communities that spans far back in history. This study not only boasts an innovative delivery model but also proves to be highly cost-effective, operating with a budget of a mere fraction of the expenses typically associated with MDMA trials. Set to take place within leading hospitals in Israel, this group therapy clinical trial marks a significant step towards rendering life-altering treatments more financially viable and accessible.

 

The event was organized by the generous support of its sponsors including Iter Investments, Kahner Global, Mystic Ventures, Negev, Segal Trials and Uptown Research Institute. 

 

The funds raised through this event support MAPS ISRAEL’s HealingOct7 Initiative. The donations will bring MAPS ISRAEL one step closer to healing those impacted by Oct. 7 and help work toward building peace in the Middle East.

 

For more information about MAPS ISRAEL and the HealingOct7 initiative, please visit: https://www.maps-israel.org/.


Photo credit: World Red Eye / Isaac Gill
Photo credit: World Red Eye / Isaac Gill
Photo credit: World Red Eye / Isaac Gill
Photo credit: World Red Eye / Isaac Gill
Photo credit: World Red Eye / Isaac Gill

By ML Staff. Images courtesy of World Red Eye/Isaac Gill

Comments


bottom of page